GovChime
Awarded

Preclinical Toxicology of Small Molecule Drugs Developed for Cancer and Other Indications

Awarded tounder 75N91022D000016 (source: SAM.gov award notice)• $9.8M

Overview

Posted
September 23, 2022
Notice type
Award Notice
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NIH National Cancer Institute
Last updated
Oct 8, 2026
Award date
Sep 23, 2022
Award amount (SAM.gov award notice)
$9.8M

Identifiers

Solicitation number
75N91021R00003
Notice ID
00ca6674dfa147529cd9bd508423f815
Award number (PIID)
75N91022D000016

Description

A Single Award Indefinite Delivery, Indefinite Quantity (IDIQ) contract was awarded in support of the Preclinical Toxicology of Small Molecule Drugs Developed for Cancer and Other Indications Program under RFP No: 75N91021R00003.

Full description on SAM.gov

Award Overview

Award Number

75N91022D000016

Award Amount (SAM.gov award notice)

$9.8M

Award Date

Sep 23, 2022

Awardee

Awardee UEI

DGBUFQYMKWB5

Awardee CAGE Code

03889

Original Solicitation

Notice ID: 00ca6674dfa147529cd9bd508423f815

Posted Date: Sep 23, 2022

Original Response Deadline: Not specified

Contract Details

Contract data not yet available

Contract details typically appear within 2-4 weeks after award; DoD awards are published about 90 days after signature.

Contacts

Contracting Officer

Primary Contact

Secondary Contact

Documents

No documents available.

Lifecycle

Solicitation:75N91021R00003
  1. Pre-Solicitation
  2. Solicitation
  3. Awarded

This opportunity has been awarded.

  1. Pre-SolicitationOct 30, 2020

    Preclinical Toxicology of Small Molecule Drugs Developed for Cancer and Other Indications

    Notice be34d9c448b04260818203b35c5784c5 on SAM.gov

  2. 8×
    SolicitationNov 20, 2020

    Preclinical Toxicology of Small Molecule Drugs Developed for Cancer and Other Indications

    Notice 1c585ad8b658478ba35dacd0595131de on SAM.gov

  3. AwardedCurrentSep 23, 2022

    Preclinical Toxicology of Small Molecule Drugs Developed for Cancer and Other Indications

    Notice 00ca6674dfa147529cd9bd508423f815 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75N91021R00003

Archive Date

Oct 8, 2022

Office Address

Rockville, MD, 20850